Invesco Ltd. - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 35 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$35,476,419
+16.6%
23,914,0000.0%0.01%
+25.0%
Q2 2023$30,430,565
-5.1%
23,914,0000.0%0.01%
-11.1%
Q1 2023$32,080,631
-14.9%
23,914,0000.0%0.01%
-18.2%
Q4 2022$37,700,421
+12.4%
23,914,0000.0%0.01%0.0%
Q3 2022$33,551,000
+6.5%
23,914,0000.0%0.01%
+10.0%
Q2 2022$31,507,000
+0.6%
23,914,0000.0%0.01%
+25.0%
Q1 2022$31,327,000
+5.1%
23,914,0000.0%0.01%
+14.3%
Q4 2021$29,818,000
-6.0%
23,914,0000.0%0.01%
-12.5%
Q3 2021$31,706,000
-0.8%
23,914,0000.0%0.01%0.0%
Q2 2021$31,971,000
-17.8%
23,914,000
-17.3%
0.01%
-20.0%
Q1 2021$38,897,000
-12.6%
28,933,000
-10.3%
0.01%
-23.1%
Q4 2020$44,529,000
-6.2%
32,273,000
-6.5%
0.01%
-18.8%
Q3 2020$47,471,000
-21.6%
34,524,000
-5.2%
0.02%
-27.3%
Q2 2020$60,521,000
+29.7%
36,399,0000.0%0.02%
+10.0%
Q1 2020$46,646,000
-16.3%
36,399,0000.0%0.02%
+17.6%
Q4 2019$55,737,000
+11.8%
36,399,0000.0%0.02%
+30.8%
Q3 2019$49,838,000
+4.9%
36,399,000
+0.6%
0.01%
+8.3%
Q2 2019$47,493,000
-2.9%
36,199,0000.0%0.01%
-25.0%
Q1 2019$48,918,000
+13.4%
36,199,000
+0.2%
0.02%
-5.9%
Q4 2018$43,131,000
-32.1%
36,132,000
-3.1%
0.02%
-15.0%
Q3 2018$63,550,000
+20.0%
37,282,000
+1.6%
0.02%
+11.1%
Q2 2018$52,941,00036,682,0000.02%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders